ADC Therapeutics S.A. (ADCT)
NYSE·Healthcare·Biotechnology
$1.49
-7.59%
Mkt Cap $201.72M
Analyst Ratings
Buy
1
Hold
1
Sell
0
Price Target (9 analysts)
$3.50
Range $2.00 – $5.00
Implied Upside
+134.9%
Consensus $3.50 vs current $1.49
NYSE·Healthcare·Biotechnology
$1.49
-7.59%
Mkt Cap $201.72M
Buy
1
Hold
1
Sell
0
Price Target (9 analysts)
$3.50
Range $2.00 – $5.00
+134.9%
Consensus $3.50 vs current $1.49